Windlas Biotech Limited (BOM:543329)

Windlas Biotech Statistics

Total Valuation

Windlas Biotech has a market cap or net worth of INR 19.30 billion. The enterprise value is 17.23 billion.

Market Cap	19.30B
Enterprise Value	17.23B

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	Jul 21, 2025

Share Statistics

Current Share Class	20.90M
Shares Outstanding	n/a
Shares Change (YoY)	+1.22%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	7.83M

Valuation Ratios

The trailing PE ratio is 31.64.

PE Ratio	31.64
Forward PE	n/a
PS Ratio	2.54
PB Ratio	3.82
P/TBV Ratio	3.87
P/FCF Ratio	120.68
P/OCF Ratio	28.31
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.31, with an EV/FCF ratio of 107.76.

EV / Earnings	28.25
EV / Sales	2.27
EV / EBITDA	18.31
EV / EBIT	26.06
EV / FCF	107.76

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.06.

Current Ratio	2.11
Quick Ratio	1.63
Debt / Equity	0.06
Debt / EBITDA	0.35
Debt / FCF	2.04
Interest Coverage	15.09

Financial Efficiency

Return on equity (ROE) is 12.76% and return on invested capital (ROIC) is 8.33%.

Return on Equity (ROE)	12.76%
Return on Assets (ROA)	5.96%
Return on Invested Capital (ROIC)	8.33%
Return on Capital Employed (ROCE)	12.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	1,154
Asset Turnover	1.10
Inventory Turnover	6.57

Taxes

In the past 12 months, Windlas Biotech has paid 187.64 million in taxes.

Income Tax	187.64M
Effective Tax Rate	23.53%

Stock Price Statistics

The stock price has increased by +27.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.10%
50-Day Moving Average	922.44
200-Day Moving Average	962.84
Relative Strength Index (RSI)	53.45
Average Volume (20 Days)	2,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Windlas Biotech had revenue of INR 7.60 billion and earned 609.94 million in profits. Earnings per share was 28.87.

Revenue	7.60B
Gross Profit	2.88B
Operating Income	661.22M
Pretax Income	797.58M
Net Income	609.94M
EBITDA	941.07M
EBIT	661.22M
Earnings Per Share (EPS)	28.87

Balance Sheet

The company has 2.39 billion in cash and 325.97 million in debt, giving a net cash position of 2.07 billion.

Cash & Cash Equivalents	2.39B
Total Debt	325.97M
Net Cash	2.07B
Net Cash Per Share	n/a
Equity (Book Value)	5.06B
Book Value Per Share	241.38
Working Capital	2.76B

Cash Flow

In the last 12 months, operating cash flow was 681.87 million and capital expenditures -521.94 million, giving a free cash flow of 159.93 million.

Operating Cash Flow	681.87M
Capital Expenditures	-521.94M
Free Cash Flow	159.93M
FCF Per Share	n/a

Margins

Gross margin is 37.90%, with operating and profit margins of 8.70% and 8.03%.

Gross Margin	37.90%
Operating Margin	8.70%
Pretax Margin	10.50%
Profit Margin	8.03%
EBITDA Margin	12.38%
EBIT Margin	8.70%
FCF Margin	2.10%

Dividends & Yields

This stock pays an annual dividend of 5.80, which amounts to a dividend yield of 0.64%.

Dividend Per Share	5.80
Dividend Yield	0.64%
Dividend Growth (YoY)	5.45%
Years of Dividend Growth	3
Payout Ratio	18.85%
Buyback Yield	-1.22%
Shareholder Yield	-0.58%
Earnings Yield	3.16%
FCF Yield	0.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6